https://www.selleckchem.com/pr....oducts/cct128930.htm
In particular, the exact molecular mechanism responsible for the regulation of the inflammasomes during carcinogenesis of EBV-associated NPC has not been explored thoroughly. Furthermore, the current practical application of inflammasome inhibitors is limited to specific tumour types, hence, further studies are warranted to discover the potential of targeting the inflammasomes for the treatment of NPC. In the latest years, there has been an increased interest in nanomaterials that may provide promising novel approaches to disease diag
Like
Comment
Share
